GIST - Klinische Problemstellungen und offene Fragen

Literatur

• 1 Hirota S, Isozaki K, Moriyama Y. et al . Gain of function mutations of c-kit in human gastrointestinal sromal tumors.  Science. 1998;  279 577-580
• 2 Hohenberger P. Neue Konzepte der Chirurgischen Therapie gastrointestinaler Stromatumoren.  Viszeralchirurgie. 2003;  38 379-386
• 3 Agaimy A, Wunsch P H, Hofstaedter F. et al . Minute gastric sclerosing stromal tumors (GIST tumorlets) are common in adults and frequently show c-KIT mutations.  Am J Surg Pathol. 2007;  31 113-120
• 4 Kawanowa K, Sakuma Y, Sakurai S. et al . High incidence of microscopic gastrointestinal stromal tumors in the stomach.  Hum Pathol. 2006;  37 1527-1535
• 5 Hohenberger P, Wardelmann E. Gastro-intestinale Stromatumoren - Was der Chirurg wissen muss.  Chirurg. 2006;  77 18-26
• 6 Blay J Y, Bonvalot S, Casali P, Choi H, Debiec-Richter M, Dei Tos A P, Emile J F, Gronchi A, Hogendoorn P C, Joensuu H, Le Cesne A, McClure J, Maurel J, Nupponen N, Ray-Coquard I, Reichardt P, Sciot R, Stroobants S, van Glabbeke M, van Oosterom A, Demetri G D. GIST consensus meeting panelists. Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO.  Ann Oncol. 2005;  16 566-578
• 7 Miettinen M, Lasota J. Gastrointestinal stromal tumors: pathology and prognosis at different sites.  Semin Diagn Pathol. 2006;  23 70-83
• 8 Wardelmann E, Pauls K, Merkelbach-Bruse S, Hrychyk A, Losen I, Hohenberger P, Buettner R, Pietsch T. Gastrointestinal stromal tumors carrying PDGFRalpha mutations occur preferentially in the stomach and exhibit an epithelioid or mixed phenotype.  Verh Dtsch Ges Pathol. 2006;  88 174-118
• 9 Lasota J, Kopczynski J, Sarlomo-Rikala M. et al . KIT 1530ins6 mutation defines a subset of predominantly malignant gastrointestinal stromal tumors of intestinal origin.  Hum Pathol. 2003;  34 1306-1312
• 10 Lasota J, Stachura J, Miettinen M. GISTs with PDGFRA exon 14 mutations represent subset of clinically favorable gastric tumors with epithelioid morphology.  Lab Invest. 2006;  86 94-100
• 11 Novitsky Y W, Kercher K W, Sing R F. et al . Long-term outcomes of laparoscopic resection of gastric gastrointestinal stromal tumors.  Ann Surg. 2006;  243 738-745 ,  discussion 745-747
• 12 Otani Y, Furukawa T, Yoshida M. et al . Operative indications for relatively small (2-5 cm) gastrointestinal stromal tumor of the stomach based on analysis of 60 operated cases.  Surgery. 2006;  139 484-492
• 13 Berindoague R, Targarona E M, Feliu X, Artigas V, Balague C, Aldeano A, Lahoud A, Navines J, Fernandez-Sallent E, Trias M. Laparoscopic resection of clinically suspected gastric stromal tumors.  Surg Innov. 2006;  13 231-237
• 14 Raut C P, Posner M, Desai J. et al . Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitors.  J Clin Oncol. 2006;  24 2325-2331
• 15 Hohenberger P, Langer C, Pistorius S. et al . Indication and results of surgery following imatinib treatment of locally advanced or metastatic GI stromal tumors (GIST).  J Clin Oncol (Annual Meeting Proceedings). 2006;  24 9500
• 16 Gronchi A, Fiore M, Miselli F. et al . Surgery of residual disease following molecular-targeted therapy with imatinib mesylate in advanced/metastatic GIST.  Ann Surg. 2007;  245 ,  (in press)
• 17 DeMatteo R P, Maki R G, Singer S A. et al . Results of tyrosine kinase inhibitor therapy followed by surgical resection for metastatic gastrointestinal stromal tumor (GIST).  Ann Surg. 2007;  245 ,  (in press)
• 18 Prakash S, Sarran L, Socci N, DeMatteo R P, Eisenstat J, Greco M, Maki R G, Wexler L H, LaQuaglia M P, Besmer P, Antonescu C R. Gastrointestinal stromal tumors in children and young adults: a clinicopathologic, molecular, and genomic study of 15 cases and review of the literature.  J Pediatr Hematol Oncol. 2005;  27 179-187